More Cyclopharm Limited news
Cyclopharm LimitedASX: CYC

Cyclopharm Receives USFDA Approval for Technegas

Oct 1, 2023 at 9:47 PM EDT · Issued by Cyclopharm Limited

Filed with ASX · Oct 1, 2023 at 9:47 PM EDT

On 6ix: 6ix.com/news/cyclopharm-receives-usfda-approval-for-technegas

Cyclopharm Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Cyclopharm Limited on 6ix

In the deck

  • Cyclopharm — Corporate Update (October 2023)22 slidesOct 5, 2023

Story so far

  • USFDA Approval Process UpdateAug 9, 2023
  • Cyclopharm Confirms USFDA Scheduled Inspection DateMay 9, 2023
  • USFDA Confirms Technegas Six Month Review PeriodApr 24, 2023

Earlier from Cyclopharm

  • Investor Presentation CorrectionSep 26, 2023
  • Cyclopharm Investor UpdateSep 25, 2023
  • Litigation Update and Receipt of Settlement PaymentAug 24, 2023
  • Half Year AccountsAug 22, 2023
  • USFDA Approval Process UpdateAug 8, 2023

Later from Cyclopharm

  • Cyclopharm Signs First USA Contract for TechnegasDec 4, 2023
  • Cyclopharm Trading and USA Launch UpdateFeb 5, 2024
  • Cyclopharm to Present at Euroz Hartleys Healthcare ForumFeb 5, 2024
  • S&P DJI Announces March 2024 Quarterly RebalanceMar 1, 2024
  • First USA Patients Imaged with TechnegasMar 18, 2024
All Cyclopharm news releases↗

Follow Cyclopharm into a list and get an email when it puts out news.

Follow Cyclopharm
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer